SANTOS DAVID A (EVP, Chief Commercial Officer) reported 1 transaction at RIGEL PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 9/3/2026ACC: 0000905148-26-004079
Officer· EVP, Chief Commercial Officer
Since Aug 2020
-874.00
Net shares
Net seller
$41.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
874.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−874.00
Price / share
$47.50
Trade value
$41.52K
% of position
1.4%
9/1/2026
62.50K→61.62K
Total
Net shares
−874.00
Net value
-$41.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | F · Tax Withholding | −874.00 | $47.50 | $41.52K | 1.4% | 62.50K | 61.62K |
| Total | −874.00 | -$41.52K | ||||||
Derivative Transactions0
No derivative transactions reported